Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism SLIT2 inhibitors(slit guidance ligand 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |










| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerular disease | Preclinical | China | 28 Mar 2024 | |
| Glomerular disease | Preclinical | Singapore | 28 Mar 2024 | |
| Glomerulosclerosis, Focal Segmental | Preclinical | China | 28 Mar 2024 | |
| Glomerulosclerosis, Focal Segmental | Preclinical | Singapore | 28 Mar 2024 |






